Go Pro
NASDAQ:KRMD

KORU Medical Systems Q2 2026 Earnings Report

KORU Medical Systems logo
$4.08 +0.25 (+6.53%)
Closing price 07/27/2026 04:00 PM Eastern
Extended Trading
$4.07 -0.01 (-0.25%)
As of 07/27/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KORU Medical Systems EPS Results

Actual EPS
N/A
Consensus EPS
-$0.02
Beat/Miss
N/A
One Year Ago EPS
N/A

KORU Medical Systems Revenue Results

Actual Revenue
N/A
Expected Revenue
$11.62 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

KORU Medical Systems Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Wednesday, August 5, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

KORU Medical Systems Earnings Headlines

How the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement Accounts
JPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a core holding rather than just a crisis hedge. Most Western portfolios still hold less than 1 percent in gold, even as the metal has already topped $5,000 and outpaced the S&P 500 in 2026. Physical gold can be added directly to an existing IRA or 401(k), with no new account, no penalty, and no tax hit.tc pixel
NASDAQ:KRMD (Koru Medical Systems)
See More KORU Medical Systems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like KORU Medical Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on KORU Medical Systems and other key companies, straight to your email.

About KORU Medical Systems

KORU Medical Systems (NASDAQ:KRMD) develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

View KORU Medical Systems Profile